Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.
Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.
复制标题
DOI:
10.1177/0961203316644331
复制
发表时间:
2016-12
期刊:
影响因子:
2.6
通讯作者:
Caricchio R
中科院分区:
文献类型:
--
作者:
Jog NR;Blanco I;Lee I;Putterman C;Caricchio R
High mobility group box 1 protein (HMGB-1) has been implicated in the pathogenesis of lupus nephritis (LN). There is increased HMGB-1 expression in the kidneys and increased levels are observed in serum and urine of patients with LN. This study was performed to determine whether the increased urinary HMGB-1 was specific for active lupus or secondary to renal damage. Urine from 61 lupus patients (32 had active LN and 29 had SLE with no evidence of LN) and 14 control proteinuric patients (all with hypertension and 8 also with diabetes) were included in this study. HMGB-1 was detected by western blot. Urine protein was normalized to urine creatinine to account for volume of the specimen. Median normalized urine HMGB-1 levels were significantly elevated in LN patients compared to lupus patients without kidney disease (53.81 vs. 9.46, p<0.001). A difference in median levels was seen between LN classes; with a significant difference between proliferative and membranous disease (33.4 vs. 138.8, p=0.003). Urine protein to urine creatinine ratio (P/C) correlated with urinary HMGB-1 (r=0.52, p<0.001), but across the classes this was true only for membranous disease (r=0.71, p=0.022, proliferative, p=0.63; mixed, p=0.34). HMGB-1 is elevated in the urine of patients with active LN. Levels are associated with LN class and higher levels of urinary HMGB-1 are seen in patients with class V when compared to both proliferative and mixed classes. Therefore, urinary HMGB-1 may be suggestive of membranous LN and warrants further evaluation in large lupus cohort and control disease.
登录
查看更多内容
影响因子:
4.9
作者:
Abdulahad DA;Westra J;Bijzet J;Limburg PC;Kallenberg CG;Bijl M
通讯作者:
Bijl M
影响因子:
4.4
作者:
Qing, Xiaoping;Pitashny, Milena;Thomas, David B.;Barrat, Franck J.;Hogarth, Mark P.;Putterman, Chaim
通讯作者:
Putterman, Chaim
影响因子:
13.6
作者:
Banas, Miriam C.;Banas, Bernhard;Alpers, Charles E.
通讯作者:
Alpers, Charles E.
DOI:
10.1084/jem.20120189
发表时间:
2012-08-27
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Venereau E;Casalgrandi M;Schiraldi M;Antoine DJ;Cattaneo A;De Marchis F;Liu J;Antonelli A;Preti A;Raeli L;Shams SS;Yang H;Varani L;Andersson U;Tracey KJ;Bachi A;Uguccioni M;Bianchi ME
通讯作者:
Bianchi ME
DOI:
10.1097/01.asn.0000108969.21691.5d
发表时间:
2004-02-01
影响因子:
13.6
作者:
Weening, JJ;D'Agati, VD;Nagata, M
通讯作者:
Nagata, M